In one paragraphArticle in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Maithreyan Kuppusamy *Central Institute for Engineering, Electronics and Analytics, ZEA-3, Forschungszentrum, Jülich, Germany.ORCID 0000-0001-6866-0417 Daniel Jacko *Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.ORCID 0000-0002-9330-4702 Yamini Gupta *Institute for Cell Biology, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany.ORCID 0009-0006-0724-6072 Sandro SiegerInstitute for Cell Biology, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany.ORCID 0009-0006-0120-6010 Kirill SchaafDepartment of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.
Martin MatijassCentral Institute for Engineering, Electronics and Analytics, ZEA-3, Forschungszentrum, Jülich, Germany.
Käthe BersinerDepartment for the Biosciences of Sports, Institute of Sports Science, University of Hildesheim, Hildesheim, Germany.ORCID 0000-0002-8107-7899 Jonas ZacherDepartment of Preventative and Rehabilitative Sports and Performance Medicine, Institute of Cardiology and Sports Medicine, German Sports University Cologne, Cologne, Germany.
Sara BoniniResearch Center One Health Ruhr, University Alliance Ruhr & University Hospital Essen Medical Faculty, University Duisburg-Essen, Essen, Germany.ORCID 0000-0001-8293-2546 Miguel Cosenza-ContrerasFaculty of Biology, University of Freiburg, Freiburg, Germany.
Peter van der VenInstitute for Cell Biology, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany.
Wilhelm BlochDepartment of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.
Dieter O FürstInstitute for Cell Biology, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany.ORCID 0000-0001-8805-6444 Dominic WinterResearch Center One Health Ruhr, University Alliance Ruhr & University Hospital Essen Medical Faculty, University Duisburg-Essen, Essen, Germany.
Jörg HöhfeldInstitute for Cell Biology, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany. hoehfeld@uni-bonn.de.ORCID 0000-0003-4403-0757 Pitter F HuesgenCentral Institute for Engineering, Electronics and Analytics, ZEA-3, Forschungszentrum, Jülich, Germany. pitter.huesgen@biologie.uni-freiburg.de.ORCID 0000-0002-0335-2242 Sebastian GehlertDepartment of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany. gehlert@uni-hildesheim.de.ORCID 0000-0001-6940-3084 Funding
Deutsche Forschungsgemeinschaft (German Research Foundation) 388932620
6 · The paper itselfAbstract
Resistance exercise (RE) improves strength and muscle mass, with multiple benefits for human health. However, intense RE also induces acute myofibrillar damage. The molecular mechanisms that preserve, mark, degrade, and restore damaged proteins to keep skeletal muscle working under RE are incompletely understood. Based on repeated sampling of human skeletal muscle, we show here that acute, repeated and interrupted RE induce dynamic changes of the protein landscape associated with the sarcomeric cytoskeleton. These changes correlate with changes in phosphorylation indicative of adaptation and deadaptation signaling footprints. Regulation mainly affects the protein network linked to the muscle maintenance protein BAG3, which includes mechanosensory proteins, small heat shock proteins, and a lipid droplet associated protein. All network components exhibit altered phosphorylation and increased cytoskeletal association after damaging RE. Moreover, network components cooperate to recognize strained skeletal muscle structures and mediate their degradation through chaperone-assisted selective autophagy (CASA). Our study thus identifies key regulators of skeletal muscle homeostasis in humans.
Indexed as
Muscle ProteinsMuscle, SkeletalProteomicsResistance TrainingAdaptor Proteins, Signal TransducingAdultApoptosis Regulatory ProteinsAutophagyHumansMalePhosphorylationProtein Interaction MapsSarcomeresAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsBAG3 protein, humanMuscle Proteins
Identifiers
PMID42521682
PMCPMC13415819
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390